» Articles » PMID: 17363239

Transcuprein is a Macroglobulin Regulated by Copper and Iron Availability

Overview
Journal J Nutr Biochem
Date 2007 Mar 17
PMID 17363239
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Transcuprein is a high-affinity copper carrier in the plasma that is involved in the initial distribution of copper entering the blood from the digestive tract. To identify and obtain cDNA for this protein, it was purified from rat plasma by size exclusion and copper-chelate affinity chromatography, and amino acid sequences were obtained. These revealed a 190-kDa glycosylated protein identified as the macroglobulin alpha(1)-inhibitor III, the main macroglobulin of rodent blood plasma. Albumin (65 kDa) copurified in variable amounts and was concluded to be a contaminant (although it can transiently bind the macroglobulin). The main macroglobulin in human blood plasma (alpha(2)-macroglobulin), which is homologous to alpha(1)-inhibitor III, also bound copper tightly. Expression of alpha(1)I3 (transcuprein) mRNA by the liver was examined in rats with and without copper deficiency, using quantitative polymerase chain reaction methodology and Northern blot analysis. Protein expression was examined by Western blotting. Deficient rats with 40% less ceruloplasmin oxidase activity and liver copper concentrations expressed about twice as much alpha(1)I3 mRNA, but circulating levels of transcuprein did not differ. Iron deficiency, which increased liver copper concentrations by threefold, reduced transcuprein mRNA expression and circulating levels of transcuprein relative to what occurred in rats with normal or excess iron. We conclude that transcupreins are specific macroglobulins that not only carry zinc but also carry transport copper in the blood, and that their expression can be modulated by copper and iron availability.

Citing Articles

Emerging perspectives of copper-mediated transcriptional regulation in mammalian cell development.

Fitisemanu F, Padilla-Benavides T Metallomics. 2024; 16(10).

PMID: 39375833 PMC: 11503025. DOI: 10.1093/mtomcs/mfae046.


Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases.

Yang Z, Feng R, Zhao H Apoptosis. 2024; 29(9-10):1330-1360.

PMID: 39014119 DOI: 10.1007/s10495-024-01993-y.


Cuproptosis in cancer: biological implications and therapeutic opportunities.

Li L, Zhou H, Zhang C Cell Mol Biol Lett. 2024; 29(1):91.

PMID: 38918694 PMC: 11201306. DOI: 10.1186/s11658-024-00608-3.


Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development.

Karpenko M, Muruzheva Z, Ilyechova E, Babich P, Puchkova L Antioxidants (Basel). 2023; 12(9).

PMID: 37759957 PMC: 10525645. DOI: 10.3390/antiox12091654.


Copper in Cancer: from transition metal to potential target.

Fang C, Peng Z, Sang Y, Ren Z, Ding H, Yuan H Hum Cell. 2023; 37(1):85-100.

PMID: 37751026 DOI: 10.1007/s13577-023-00985-5.


References
1.
Matthijs G, Devriendt K, Cassiman J, Van Den Berghe H, Marynen P . Structure of the human alpha-2 macroglobulin gene and its promotor. Biochem Biophys Res Commun. 1992; 184(2):596-603. DOI: 10.1016/0006-291x(92)90631-t. View

2.
Cox L, Kennedy M, Adrian G . The 5'-untranslated region of human transferrin mRNA, which contains a putative iron-regulatory element, is bound by purified iron-regulatory protein in a sequence-specific manner. Biochem Biophys Res Commun. 1995; 212(3):925-32. DOI: 10.1006/bbrc.1995.2058. View

3.
Breslow E . COMPARISON OF CUPRIC ION-BINDING SITES IN MYOGLOBIN DERIVATIVES AND SERUM ALBUMIN. J Biol Chem. 1964; 239:3252-9. View

4.
MASUOKA J, Hegenauer J, Van Dyke B, Saltman P . Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin. J Biol Chem. 1993; 268(29):21533-7. View

5.
. Report of the American Institute of Nurtition ad hoc Committee on Standards for Nutritional Studies. J Nutr. 1977; 107(7):1340-8. DOI: 10.1093/jn/107.7.1340. View